5 ?
32
0??NM? ?ù
SpecialForumS
ó?sè ^?ó5%h¥×
12By íV7°m?| ì¥
1?bó?sè¥eys1e??
????b????ó?sè ''
v?s ^??t ¤?%h ?á
Kèn¥ ?UhaJF??
h|?(e?Jh)# ¤? /#%h
?t0t9??Yó?}?7
?áó?sèb?Jh ^?á
???ó?sè¥èneyb
Jháó?sè¥?
3 ?4 ¥JF í;?
\é?%???}?¥K ? ?β-?
-β-J-?= ???£ ?A(HMG-
CoA)?e ?¥??] H?4ú
HMG-CoA?e ?¥?V7 V
\é?%?¥????4ú7α
?? ?#§ y ?¥?\é?%
??1?? ?bJF í??
9F% ? á??a?%?
(low-densitylipoproteincholesterol
LDL-C) s8 ?"#?\é
LDL-C?3i?2??[
?(triglyceridelipaseHSL)\é
?[??#?[ ?¥?b Pó}
9?%?(totalcholesterolTC) £ü
??b
Jh HJF í £ü?
??%?¥??T¨<??3
#?T¨óbTC £ü 6úO
??LDL-C s8 ?"h LDL-C
?3 ?h ¤i 6úb#
Jh HB?VC1TCaLDL-Ca
ApoB?Lp(a) 6úμ H V?μ?
2?(triglycerideTG)¥ 6ú
ú á??a?%?(high-density
lipoproteincholesterolHDL-C)B?
í üAM?
[1]
b] Hù?9?C
ú?%?ó????Jh¥?h q
?14.3%?e??Jh3.7%
[2]
b
Jháó?sè¥í
JF í
1
W@t EM} 7 SJ
F íX¨?Jháó?sè¥í
b"-JF í V??Jh?
?¥ó?sèXr? Mbù?
V üPJF í(levothyroxine
LT
4
)í 8? V P?75%¥Jh??
uE +`?ê 8 ?D
y=s ? S????D
=b?êvD? qp V 3
? =b?ê 8 "5DDù?
y=s ?}?ù? ? ?éb
? 3?l DE?S
? 3"d5éyT?b??
SE1? SDáaa
EB?|êaS=?T?[
"bSE S/é?=??
[?ê 8 S/B??
[ 8?)=??[b?
V ?ó?é?4$ ?
ó?éb
T
reatmentofhypothyroidisminduced
bybloodlipidabnormality
Jháó?sè¥í
?ê 8 ?Dy=s ? SuE +
?ms ?|``óDS M ?`"``ócI|`
1oMJF??h|?ó?sè0tí
5 ?
M? ?ù
0??N
33
SpecialForum
ó??ˉ?èb??Jh?? ???ó5%h¥ú
2|? ??×g?¥ ''üao?#?μúóa
h¥???? ?Jh???Yèwi P¨DLT
4
ó?¥??í b
"-¥ù?éZ1Jháó?sè¥í 4
֐4??0tDLT
4
¥ ó??¨ "5Z ? V
[4÷mb
eR ?0t
eR ?0t???ó5 YqZ ?¥T¨X P
?1??%?í ¥áS eR ?0tJháó
?sè¥í ?g?T1 nêby1 eR ?0t VE
HMG-CoA?e ??7LT
4
VYVLDL-C s
87á ??3?%? ?[ eR ?0t ó?LT
4
V ü
A??LDL-Cb] H eR ?0t? μ üA¥ F
T¨V7 V?JF7?áJh¥??9 ^μ
m¥
[3]
b
eR ?0t ^???%?1???μr¥0tb
? ^Jh?? V?? ?¥ üA 6úbe?
?Jh¤ sv4
eR ?0tí
H .àμ V?? 3
??·3
[4]
byNX P¨ eR ?0t7J??
?è¥?? P¨LT
4
9}í XT07ˉ P¨ e
R ?0t¥????ì?è 0?t|? ^? 3 eR
?0t ?áh¥ú2|?b3á??¨ eR ?0t
í ¥???Ce???# HáóD =[
? ^?? 3hi# H??0tí b31
P¨???0 sv4
eR ?0t¥??3ê4
e9}¥n @b
Jh??'' P ^e "5Jh???T ^M
-<65 ?aTSHú?10mIU/L¥?ó5%h¥ú2|
???é?M?í
[5]
b? eR ?0t ó? I
?? ?JF í¥? óí V] HT¨??%?¥
??a l?b" ^ Vê4¥Z?-Bb
K?ù??CJF í ? ?tepotiome ó?
?B eR-?B eRí ú?%?ó??? V ü
A??á? ???¥??ar32%[
[6]
b??J
F í ? ?t P¨??O??Mó}TSHi"
- ?43??#??¥? Q? V??1
í Jháó?sè¥B??¥??μr¥0tb
I ??
I ?? ^B?ü?¥?? ?>?4l
? Vê4?¥2???? ?
[7]
Pó}LDL-C¥b
"9Fbíù¥?A U| ??? ? V?T
1?|s0YVG} ó?a s8TGR5Y ^?Y?
h{?á%=ì
?F ?(cyclicadenosine
monophosphatecAMP) £ü 6ú?á??JF
e? ? 3?9Fb+s??? ?>?4 I ?? V
P=÷??? ?/??40% VO?%??1?
? ?9FV7??LDL-Cr20%
[8]
bN? ?D e
R ?0t ó¨? V[??ú ùCQ??a(Creactive
proteinCRP)byN I ?? ó? eR ?0t?J
F í ^í Jháó?sè¥μrn @b? I ??
VDLT
4
2??? l#??¨LT
4
1j4h
a P¨ I ?? bèn? Q?1L Yah??
a′Dae?b
?0
?0í ó?sèZ ?μ V L¥ "5 r?
z¥????¨ZLaNì? ÷aGV?zbè
¨¥??0 ???aa?A?aó? B?b0??
ü?4í ú?ó?¥??0tμ??''6?a
???? néb?0??¥μr?s ?| &0a
?" ?90a 2¤a6?R?a % ü0av?
pav × íaˉp?30?? V? ó?sè¥?
] ??é?ê4b?0í ó??¨ H3?i V
?¥? Q?μt ??£aúóaúU ?ó?a
h??? aaé ?]?h?? ??b
3Z T??
3Z T???1 ?? e?8×b|8× e
??èS?= V??ó?sè? 3¥2B9μù
??i?×g?¥Jh??ó?sè¥??b??
?? Jb?? ? e?9£ ? ?ó?! íh
Jt??[- ^??[ ?? J? ?]1×b
è?b??μ? p¥?μù????[}??
?óTCaTGaLDL-C 6úHDL-C? Vi
4ú???[%??a? ?¥?\é?[
5 ?
34
0??NM? ?ù
SpecialForumS
s39F3 ??[ ?¥? ?¨°¤W¤1?
?ó?}? ?béμ?K?b @?hDù?A U
μ? V üA??ó?}? ?i??3?h?Bb
?ú"4÷? ?? VO?[F? db?
[ ? Pé#??TG¥-8? á??a?%?
(verylow-densitylipoproteincholesterolVLDL-C)9
Fi PVLDL-C#? ?± ìVó?b"h ¤7?á
TG 6ú
[9]
b
9-Jháó?sè¥???"LT
4
?
3Z T???? I n? eR ?0tí b?
LDL-Cˉ?rS5wi ó? e??0tbD 3
óíJháó?sè????í -? s 3ò ?
0tW¥MoT¨a0 s?????b ó?í ?
μú?ó5%h?B¥Jháó?sè?? ? a÷1
A1
[10]
b
? IóD
[1]BauerDC,EttingerB,BrownerWS.Thyroidfunctionsandserum
lipidsinolderwomen:apopulation-basedstudy[J].AmJMed,1998,
104(6):546-551.
[2]TagamiT,KimuraH,OhtaniS,etal.Multi-centerstudyonthe
prevalenceofhypothyroidisminpatientswithhypercholesterolemia[J].
EndocrJ,2011,58(6):449-557.
[3]KrysiakR,OkopienB.Theeffectofsimvastatinonlymphocyte
secretoryfunctioninpatientswithimpairedfastingglucose[J].J
CardiovascPharmacol,2010,56:491-497.
[4]KiernanTJ,RochfordM,McDermottJH.Simvastatininduced
rhabdomyolysisandanimportantclinicallinkwithhypothyroidism[J].
IntJCardiol,2007,119,374-376.
[5]RotondiM,denElzenWP,BauerDC,etal.Subclinicalhypothyroidism
andtheriskofcoronaryheartdisease[J].JAmMedAssoc,2010,304:
1365-1374.
[6]LadensonPW,KristensenJD,RidgwayEC,etal.Useofthethyroid
hormoneanalogueeprotiromeinstatin-treateddyslipidemia[J].NEngl
JMed,2010,362:906-916.
[7]WatanabeH,HoutenSM,MatakiC,etal.Bileacidsinduceenergy
expenditurebypromotingintracellularthyroidhormoneactivation[J].
Nature,2006,439:484-489.
[8]InsullWJ.Clinicalutilityofbileacidsequestrantsinthetreatmentof
dyslipidemia:ascientifcreview[J].SouthMedJ,2006,99:257-273.
[9]tE ù. L¨ó?D(?1?)[M].?:| ?? 3? ,2010.
[10]DuntasL,KolovouG.Optionsforthetreatmentofhyperlipidemia
intype2diabetesmellitusandhypothyroidism:loweringthe
cardiovascularrisk[J].FutureCardiol,2011,7(2):137-144.
là°ù2012-2-20¤ l°ù2012-3-15
¤?:
? IóD
[1]RapaA,MonzaniA,MoiaS,etal.Subclinicalhypothyroidismin
childrenandadolescents:awiderangeofclinical,biochemical,and
geneticfactorsinvolved[J].JClinEndocrinolMetab,2009,94(7)
2414-2420.
[2]KaplowitzPB.Subclinicalhypothyroidisminchildren:normal
variationorsignofafailingthyroidgland[J]?IntJPediatrEndocrinol,
2010:1-8.
[3]RagoT,ChiovatoL,GrassoL,etal.Thyroidultrasonographyasa
toolfordetectingthyroidautoimmunediseasesandpredictingthyroid
dysfunctioninapparentlyhealthysubjects[J].JEndocrinolInvest,
2001,24:763-769.
[4]RapaA,MonzaniA,MoiaS,etal.Subclinicalhypothyroidismin
childrenandadolescents:awiderangeofclinical,biochemical,and
geneticfactorsinvolved[J].JClinEndocrinolMetab,2009,94(7):
2414-2420.
[5]O''GradyMJ,CodyD.Subclinicalhypothyroidisminchildhood[J].
ArchDisChild,2011,96(3):280-284.
[6]DeLucaF,WasniewskaM,ZirilliG,etal.Attheendofatwo-year
follow-upelevatedTSHlevelsnormalizeorremainunchangedinmost
thechildrenwithsubclinicalhypothyroidism[J].ItalJPediatr,2010,
30(36):11.
[7]CerboneM,BravaccioC,CapalboD,etal.Lineargrowtha
intellectualoutcomeinchildrenwithlong-termidiopaticsubclinical
hypothyroidism[J].EurJEndocrinol,2011,164(4):591-597.
[8]FavaA,OliverioR,GiulianoS,etal.Clinicalevolutionofautoimmune
thyroiditisinchildrenandadolescents[J].Thyroid,2009,19(4):361-367.
[9]MarkovicS,KosticG,IqrutinovicZ,etal.Hashimoto''sthyroiditisin
childrenandadolescents[J].SrpArhCelokLek,2008,136(5-6):262-266.
[10]LafranchiSH.Approachtothediagnosisandtreatmentofneonatal
hypothyroidism[J].JclinEndocrinolMetab,2011,96(10):2959-2967.
[11] +Z ,?£?,;D?,?.8`e "5JF??h|?? ?¥
?Y#9}í ¥N′[J].?êD SvDD,2006,41(3):338-340.
[12]JensovskyJ,RuzickaE,SpackovaN,etal.Changesofeventrelatedpotential
andcognitiveprocessesinpatientswithsubclinicalhypothyroidismafter
thyroxinetreatment[J].EndocrRegul,2002,36(3):115-122.
[13]CalaciuraF,MottaRM,MiscioG,etal.Subclinicalhypothyroidisminearly
childhood:afrequentoutcomeoftransientneonatalhyperthyrotropinemia[J].
JClinEndocrinolMetab,2002,87(7):3209-3214.
là°ù2012-3-20¤ s°ù2012-4-8
|
|